Evolution of the Average Target: AstraZeneca PLC

Evolution of the Target Price: AstraZeneca PLC

Changes in Analyst Recommendations: AstraZeneca PLC

1da0df15460e7068adcd3.9ObE_9ahKS2ncK9RvhoZ5IJVUKcYdofImfUQ8IbGebQ.s6KRjYzlZEjWR5wI7StLjsdlO8VXPOGc_5wpmdmRL-u9v6KytJZsapYl3A~20daefe9a5b1303065454d3192c26278
01:13pm AstraZeneca: Share price weakness of late, should be capitalised on Alphavalue
09-03 AstraZeneca Kept at Buy as Berenberg Notes Upcoming COPD Data Readout MT
09-02 AstraZeneca PLC : Deutsche Bank reiterates its Sell rating ZD
09-01 AstraZeneca PLC : JP Morgan reaffirms its Buy rating ZD
08-28 AstraZeneca PLC : Jefferies reaffirms its Buy rating ZD
08-25 AstraZeneca PLC : Gets a Sell rating from Deutsche Bank ZD
08-24 JPMorgan raises Diploma, Barclays cuts Unite AN
08-20 Cancer vaccines finally garner the spotlight Alphavalue
08-20 Goldman likes Astra; JPMorgan lowers Trainline AN
08-20 AstraZeneca PLC : Goldman Sachs reaffirms its Buy rating ZD
08-19 AstraZeneca PLC : Deutsche Bank reiterates its Sell rating ZD
08-19 AstraZeneca PLC : UBS reiterates its Buy rating ZD
08-17 BofA Notes AstraZeneca's Volrustomig Late-stage Study Fail; Buy Maintained MT
08-17 AstraZeneca PLC : JP Morgan remains its Buy rating ZD
08-12 A No to BMS can open doors for a Yes to GSK Alphavalue
08-07 AstraZeneca PLC : Jefferies reaffirms its Buy rating ZD
08-04 Bristol Myers Squibb Potential Deal With AstraZeneca Seen Unlikely as Shareholder Views Diverge, RBC Says MT
08-04 ASTRAZENECA : UBS keeps its Buy rating ZD
08-04 ASTRAZENECA : Deutsche Bank keeps a Sell rating ZD
08-03 AstraZeneca Shares 'Likely Remain Depressed' Amid Mega Merger Deal, Berenberg Says; Stock Down 8% MT
08-03 AstraZeneca: BMS acquisition idea holds more red flags than green for AstraZeneca Alphavalue
08-03 ASTRAZENECA : Jefferies keeps its Buy rating ZD
08-03 ASTRAZENECA : Gets a Buy rating from JP Morgan ZD
07-29 ASTRAZENECA : Gets a Buy rating from Bernstein ZD
07-29 Deutsche Bank cuts Diageo and Luceco AN

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+13.4%
-1%
+6.29%
+3.87%
-5.08%
+29.44%
-12.53%
+2.71%
+4.09%
Average +4.58%
Weighted average by Cap. +5.84%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
164.42USD
Average target price
213.00USD
Spread / Average Target
+29.54%
High Price Target
271.18USD
Spread / Highest target
+64.93%
Low Price Target
151.95USD
Spread / Lowest Target
-7.59%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
-